로딩 중…
지수 로딩 중…
Apnimed Inc. Common Stock
APMD· NASDAQ· Health Care
$16.39-5.45%
2026-10-30
Valuation Metrics
Apnimed Inc. Common Stock's Market Cap is $653M. Ranked #2617 of 3,116 in US market (top 84%), #1114 of 1,472 on NASDAQ (top 76%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $653M | US#2,617/3,116 |
| Employees | 65 | US#2,667/3,116 |
| Performance | ||
| 1M Return | -25.17% | US#2,997/3,116 |
| From 52W High | -53.54% | US#2,682/3,116 |
| 1Y MDD | -49.63% | US#2,361/3,116 |
| Trading | ||
| Volume | 443,736 shares | US#1,483/3,116 |
| Trading Value | $7M | US#1,965/3,116 |
Company Info
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.